ArticleFrontiers in immunology2023

Demethyleneberberine alleviated the inflammatory response by targeting MD-2 to inhibit the TLR4 signaling.

Yaxing Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.